Hosted on MSN1mon
FDA beats EMA to most approved new drugs in 2024
The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in 2024. On 15 January, the two agencies ...
Nasdaq1mon
X4 Pharmaceuticals' Mavorixafor MAA for WHIM Syndrome Validated by EMA Following US Approval
The EMA previously granted orphan designation to mavorixafor in WHIM syndrome. In April 2024, mavorixafor received U.S. Food and Drug Administration approval as XOLREMDI , an oral, once-daily ...
GEN27d
C3i Center Receives EMA Approval to Manufacture Cell Therapy Products for Europe
The Montreal-based C3i Center obtained regulatory approval from the European Medicine Agency (EMA) to produce cell therapy therapies for the European market. The company obtained a certificate of ...
Business Insider26d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
MONTRÉAL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the ...
Financial Post27d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
MONTRÉAL, Feb. 19, 2025 (GLOBE NEWSWIRE) — C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the ...